FDA Approved: AKYNZEO — Supplemental Application (Helsinn Therapeutics (U.S.), Inc.)

View source ↗

Summary

FDA approved a supplemental application for AKYNZEO (netupitant and palonosetron) to update its labeling per Helsinn’s submission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Akynzeo (netupitant/palonosetron)

Snippet

SUPPL AP for AKYNZEO (NETUPITANT AND PALONOSETRON)